Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-554-2 | CAS number: 826-36-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Acceptable, well documented study report which meets basic scientific principles. The fith strain (E. coli) was also tested. Deficiencies: non-GLP, repeat experiments not performed for all strains but as shown in the supporting study, the result is reducable and no contradictory results occurred.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- (only 4 concentrations tested)
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2,2,6,6-tetramethyl-4-piperidone
- EC Number:
- 212-554-2
- EC Name:
- 2,2,6,6-tetramethyl-4-piperidone
- Cas Number:
- 826-36-8
- Molecular formula:
- C9H17NO
- IUPAC Name:
- 2,2,6,6-tetramethylpiperidin-4-one
- Details on test material:
- - Expiration date of the lot/batch: July 1996
Constituent 1
Method
- Target gene:
- his- / trp-gene
Species / strain
- Species / strain / cell type:
- other: Salmonella typhimurium TA 98, TA 100, TA 1535, TA 1537 and E. coli WP2 uvrA
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver post mitochondrial supernatant (S9 fraction)
- Test concentrations with justification for top dose:
- - Range in the cytotoxicity test: 20.57 - 5000 µg/plate;
- Range in the mutagenicity test: with/without metabolic activation: 625 - 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: bidistilled water
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: see below: details on test system and conditions
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
0.1 ml of the overnight cultures were mixed with 2 ml of top agar, either 0.5 ml of 100 mM sodium phosphate buffer (experiments without activation) or 0.5 ml of the activation mixture (Rat liver S9 fraction: 100 µl/ml, NADP: 4 µmol/ml, MgCl2: 8 µmol/ml, KCl: 33 µmol/ml, Na-phosphate-buffer, pH 7.4: 100 µmol/ml, Glucose-6-phosphate 5 µmol/ml; experiments with activation) and 0.1 ml of a solution of the test substance, the positive control or the solvent as a negative control and poured on minimal agar in Petri dishes. Each Petri dish contained about 20 ml of minimal agar (1.5% agar supplemented with 2% salts of the Vogel-Bonner Medium E and 2% glucose). The top agar was composed of 0.6% agar and 0.6% NaCl. In the experiment with Salmonella the top agar was supplemented with 10% of 0.5 mM L-histidine and 0.5 mM (+)biotin dissolved in water. In the experiment with E. coli it was supplemented with 10% of 0.5 mM L-tryptophan dissolved in water. The plates were inverted and incubated for about 48 hours at 37 ± 1.5°C in darkness. Thereafter, they were evaluated by counting the number of colonies and determining the background lawn. Colonies were counted electronically with an Artek counter.
Positive controls (without metabolic activation):
- TA 100: sodium azide in bidist. water (5.0 µg/plate);
- TA 1535: sodium azide in bidist. water (5.0 µg/plate);
- E.coli WP2 uvrA: 4-nitroquinoline-N-oxide in DMSO (2.0 µg/plate);
- TA 98: 2-nitrofluorene in DMSO (20.0 µg/plate);
- TA 1537: 9-aminoacridine in DMSO (150.0 µg/plate);
Positive controls (with metabolic activation):
- TA 100: 2-aminoanthracene in DMSO (2.5 µg/plate);
- TA 1535: cyclophosphamide*H2O in bidist. water (400.0 µg/plate);
- E. coli WP2 uvrA: 2-aminoanthracene in DMSO (50.0 µg/plate);
- TA 98: 2-aminoanthracene in DMSO (2.5 µg/plate);
- TA 1537: 2-aminoanthracene in DMSO (2.5 µg/plate);
- Evaluation criteria:
- Assay acceptance criteria:
A test is considered acceptable if the mean colony counts of the control values of all strains are within the acceptable ranges and if the results of the positive controls meet the criteria for a positive response. In either case the final decision is based on the scientific judgement of the Study Director.
Criteria for a positive response:
The test substance is considered to be mutagenic in this test system if:
A positive effect is observed in one strain and the effect can be reproduced in a confirmatory experiment. A positive effect is observed in two or more strains. A positive effect is defined as an increase of the mean number of revertants per plate for any concentration above that of the negative control by at least a factor of 2.0 with strains TA 98, TA 1535, TA 1537 and WP2 uvrA, or by a factor of at least 1.5 with strain TA 100. Generally a concentration-related effect should be demonstrable. If equivocal results are obtained, the final decision has to be based on scientific judgement. - Statistics:
- Means and standard deviations for all mutagenicity assays were calculated by a previously validated computer program.
Results and discussion
Test results
- Species / strain:
- other:
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: not observed
RANGE-FINDING/SCREENING STUDIES:
The concentration range of TK 11831 to be tested in the mutagenicity test was determined in a preliminary toxicity test. The toxicity test was carried out with strains S. typhimurium TA 100 and E.coli WP2 uvrA without and with metabolic activation at six concentrations of the test substance and one negative control. The highest concentration applied was 5000 µg/plate. The five lower concentrations decreased by a factor of 3. The plates were inverted and incubated for about 48 hours at 37 ± 1.5°C in darkness. The numbers of revertant colonies were not reduced. From the results obtained, the highest concentration suitable for the mutagenicity test was selected to be 5000 µg/plate without and with metabolic activation.
COMPARISON WITH HISTORICAL CONTROL DATA: negative and positive historical control data and acceptable ranges for negative controls were available
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Strain | Metabolic activation system | mean his+/trp+revertant colonies (negative control) | maximum revertant factor (conc. (µg/plate)) | dose dependency | Assessment | maximum revertant factor (positive control) |
TA 98 | no | 13 | 1.31 (1250) | no | negative | 107.62 (2-nitrofluorene) |
yes | 28.5 | 1.07 (625 / 5000) | no | negative | 30.63 (2-aminoanthracene) | |
TA 100 | no | 113 | 0.95 (5000) | no | negative | 8.92 (sodium azide) |
yes | 129.5 | 0.96 (5000) | no | negative | 5.75 (2-aminoanthracene) | |
TA 1537 | no | 8 | 0.88 (1250) | no | negative | 218.50 (9-aminoacridine) |
yes | 5.5 | 1.64 (1250) | no | negative | 16 (2-aminoanthracene) | |
TA 1535 | no | 15 | 1.03 (5000) | no | negative | 61.47 (sodium azide) |
yes | 13 | 1.31 (5000) | no | negative | 31.19 (cyclophosphamide) | |
E. coli WP2 uvrA | no | 21 | 1.21 (2500) | no | negative | 30.4 (4-NQO) |
yes | 30 | 0.83 (1250) | no | negative | 45.87 (2-aminoanthracene) |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
